about
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancerHigh dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancerAdvanced MRI in malignant neoplasms of the uterus.Estradiol regulation of constitutive and keratinocyte growth factor-induced CCL20 and CXCL1 secretion by mouse uterine epithelial cells.Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescenceHigh expression of mTOR is associated with radiation resistance in cervical cancerIntra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer.Radiation effects on DNA content of cervical cancer cells: A rapid evaluation of radiation sensitivity by laser scanning cytometry.Doxycycline inhibits proliferation and induces apoptosis of both human papillomavirus positive and negative cervical cancer cell lines.Symptomatic presentation with cervical cancer in Uganda: a qualitative study assessing the pathways to diagnosis in a low-income countryLamellipodin-Deficient Mice: A Model of Rectal Carcinoma.Physical and psychosocial side-effects of brachytherapy: a questionnaire survey.Role of the stem cell niche in the pathogenesis of epithelial ovarian cancers.Awareness of cervical cancer risk factors and symptoms: cross-sectional community survey in post-conflict northern Uganda.Promising Nanocarriers for PEDF Gene Targeting Delivery to Cervical Cancer Cells Mediated by the Over-expressing FRα.De-repression of the RAC activator ELMO1 in cancer stem cells drives progression of TGFβ-deficient squamous cell carcinoma from transition zones.Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy.Anti-c-Met antibody bioconjugated with hollow gold nanospheres as a novel nanomaterial for targeted radiation ablation of human cervical cancer cellTherapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression.Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy.Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development.Single-Nucleotide Polymorphisms and Haplotypes of Intercellular Adhesion Molecule-1 in Uterine Cervical Carcinogenesis in Taiwanese Women.Kaempferia parviflora Extract Exhibits Anti-cancer Activity against HeLa Cervical Cancer Cells.Clinical significance of HIF-2α immunostaining area in radioresistant cervical cancer.Identification of epithelial label-retaining cells at the transition between the anal canal and the rectum in mice.Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy.Relationships of single nucleotide polymorphisms of monocyte chemoattractant protein 1 and chemokine receptor 2 with susceptibility and clinicopathologic characteristics of neoplasia of uterine cervix in Taiwan women.Single-nucleotide polymorphisms and haplotypes of membrane type 1-matrix metalloproteinase in susceptibility and clinical significance of squamous cell neoplasia of uterine cervix in Taiwan women.XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis.Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.Stem Cell Pathology.Association of single-nucleotide polymorphisms of high-mobility group box 1 with susceptibility and clinicopathological characteristics of uterine cervical neoplasia in Taiwanese women.KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer.Semi-quantitative expression of tissue inhibitor of matrix metalloproteinase-2 in cancer of uterine cervix.The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.FEZF1 is an Independent Predictive Factor for Recurrence and Promotes Cell Proliferation and Migration in Cervical Cancer
P2860
Q24193126-80FA62EF-F655-440A-8576-60EB1BF22665Q24234352-F125B2E6-2BFD-466A-A026-9835CB15D2D4Q30586370-68998132-A834-4EF7-9A60-7DD14E282203Q33748030-C9D2F2C7-DDF4-4EBF-A660-ECE85FA1BA8BQ33933870-B42EFC26-06F7-433B-A324-0803F7014DD4Q34167071-461B40EB-4E82-44EC-82AF-B4141D7615F1Q34543718-7FCAE40E-BABF-48D3-A096-B61C431CD654Q34607347-2D7BEA5D-72E2-4A8C-A663-2B29E6228A18Q34675887-3CD61C2F-392F-4C86-B50B-15802122A3B8Q35109669-8E7A40F1-BDF3-4FB0-8355-2B8D24D3BD10Q35979867-93E18A60-8309-4CD3-B59B-EC9F936F3105Q36328572-82682EC4-4169-4D1F-9B54-451C31E7C5D4Q36997578-6DF72BED-5DFE-4BC6-BAED-A72765342B03Q37118779-E9AD083E-FD51-44AA-AE6B-48AA22C46F3EQ37220620-F84C5C63-9672-4756-8668-448B4148AC12Q37656680-E1746CD6-4FAD-4D16-AB5F-EE5CC709F305Q37665239-CE4D1B45-1B59-4CC5-A30B-317D0B0FDF50Q38695456-C79CD195-DB6C-445E-8AD2-BEC26B75BED7Q38731951-1DCC5F8A-D132-416A-A59B-991AA8FC3F3BQ39377146-01ED2E5D-D456-4EB9-940C-7B1BCF90A0FDQ39488257-B6F3640B-F5CA-45F3-B554-09D39CAB748DQ41197386-81E9DFD3-2A60-48E6-B2FA-8569B21F7028Q41349472-1AAEDFFF-96BB-4545-A385-D620E7E62D1AQ41684505-FAB75872-0450-4385-880C-B5322C5DB54EQ41841034-5748F668-555C-4AFD-817B-6AE9141F933AQ42474677-B408E0B6-5E58-4EDB-81E1-31622DD64A54Q43572871-F1BD7929-47E5-4E28-9A2C-AF181BD0A01EQ44707490-A14D2C61-43FC-47AA-A2E6-D9E61EC30019Q45265587-314EC05D-C79E-41E4-8734-59EFD591FCD3Q48625360-C71BC9FF-CBD1-4C71-9D1B-F71CD80520F2Q49450258-BC5FCB4C-01C7-4364-A8BD-ACB938D0AFD0Q50068467-0679D95A-C64D-4B0E-AA20-D6D445C069C5Q51430290-F2A151AB-35E2-4A94-85AA-C90D5BAAE418Q52595286-9E8162AF-3813-49AD-8942-74A35F63E708Q53288721-FC318314-4B89-4200-B047-22936ABE0CAAQ54215275-56129FD3-0617-47FD-8410-43504A2431C1Q54322936-B975F533-B19D-4C7A-BA58-7C48505CC3C5Q58576736-36FE51E8-516D-4565-9083-C6AB6D997170
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Diagnosis and management of cervical cancer
@ast
Diagnosis and management of cervical cancer
@en
type
label
Diagnosis and management of cervical cancer
@ast
Diagnosis and management of cervical cancer
@en
prefLabel
Diagnosis and management of cervical cancer
@ast
Diagnosis and management of cervical cancer
@en
P2860
P1433
P1476
Diagnosis and management of cervical cancer
@en
P2093
Michel Roy
Patrick Petignat
P2860
P304
P356
10.1136/BMJ.39337.615197.80
P407
P577
2007-10-01T00:00:00Z